The commercial value of this combination depends on matching it to cramping or colicky pain rather than treating it as another general painkiller. By the end, you will know which patient patterns support its use, how it compares with nearby combinations, what safety controls a distributor needs, and which documents matter before accepting a Haryana franchise opportunity.
Key takeaways
- Use it for pain with suspected smooth-muscle spasm, not routine inflammatory pain.
- Compare aceclofenac 100 mg and drotaverine 80 mg against the patient’s pain pattern.
- Check contraindications, NSAID risks, interactions, dose instructions, and referral triggers.
- Verify the manufacturer’s licence, batch records, labelling, and territory terms before supply.
When does aceclofenac plus drotaverine fit a patient’s pain pattern?
This combination fits pain with suspected smooth-muscle spasm, not every painful condition. Aceclofenac 100 mg reduces pain and inflammation, while drotaverine HCl 80 mg relaxes smooth muscle. That makes it a logical option for colicky or cramping gastrointestinal pain, biliary pain, or urinary-tract pain when spasm forms part of the pattern.
Drotaverine does not treat the cause of abdominal pain. It will not clear an obstruction, cure an infection, heal an ulcer, or treat appendicitis. Uncomplicated muscle strain and routine joint pain are poor fits because they do not involve visceral smooth-muscle spasm; promoting this product for those complaints encourages a mismatch between formulation and symptom.
Unexplained abdominal pain also requires caution. Analgesic and antispasmodic effects can quiet symptoms while delaying recognition of a surgical or infectious problem. A distributor considering an aceclofenac drotaverine tablet franchise should direct the patient to medical assessment rather than promote symptom suppression when any of these signs appear:
- Severe pain or pain that persists or worsens
- Fever or repeated vomiting
- Blood in vomit or stool
- Abdominal guarding or marked tenderness
- Fainting, marked weakness, or suspected urinary or intestinal obstruction
Describe the full composition on every product and promotional document. Calling it only an “aceclofenac tablet” can lead to substitution with an aceclofenac-only product and erase the reason drotaverine was included.
How should you compare this tablet with other aceclofenac combinations?
Compare the mechanism being added, not just the word “painkiller.” Aceclofenac 100 mg plus drotaverine 80 mg combines an NSAID for pain and inflammation with a smooth-muscle antispasmodic for suspected visceral spasm. That makes it different from combinations aimed at broader analgesia or skeletal-muscle spasm.
| Option | Added component and main rationale | When it applies |
|---|---|---|
| Aceclofenac 100 mg + drotaverine 80 mg | Drotaverine targets smooth-muscle spasm | Colicky or cramping gastrointestinal, biliary or urinary-tract pain when spasm is suspected |
| Aceclofenac 100 mg + paracetamol 325 mg | Paracetamol adds another analgesic mechanism | Pain where additional analgesia is needed without selecting a skeletal-muscle relaxant |
| Aceclofenac + thiocolchicoside | Thiocolchicoside is considered for skeletal-muscle spasm | Painful muscle spasm, such as selected acute musculoskeletal conditions |
| Aceclofenac + chlorzoxazone | Chlorzoxazone is considered for skeletal-muscle spasm | Muscular tightness or spasm where a centrally acting muscle relaxant is prescribed |
Do not describe these products as interchangeable. Drotaverine is not a substitute for thiocolchicoside or chlorzoxazone, and paracetamol does not target smooth-muscle spasm. An aceclofenac 100 mg distributor should print the complete composition on every product list, visual aid and order document.
That detail prevents a pharmacy from substituting an aceclofenac-only tablet for the combination. Ask the prescriber or pharmacist to confirm the intended product whenever the invoice, prescription or pack says only “aceclofenac tablet.”
What counselling and safety checks must accompany every supply?
Every supply needs counselling, not just a carton handover. Tell the patient to follow the prescriber’s dose and frequency, use the shortest necessary duration, and take the tablet with food if advised to reduce stomach irritation. After a missed dose, take the next scheduled dose; never double it.
Before dispensing, ask whether the patient has:
- An NSAID allergy, asthma or a previous serious reaction to painkillers
- An active ulcer, gastrointestinal bleeding or black stools
- Kidney disease, liver disease, uncontrolled hypertension or heart disease
- Pregnancy, attempted conception or breastfeeding requiring prescriber review
- Another product containing aceclofenac, diclofenac, ibuprofen, naproxen or paracetamol
Do not treat this screening as a substitute for clinical assessment. A drotaverine 80 mg pharma distributor must ensure counselling also covers dizziness, nausea, headache, palpitations and low blood pressure. Advise caution with driving or standing quickly if dizziness occurs, especially in a patient with low blood pressure or significant liver, kidney or cardiac disease.
Stop the medicine and obtain urgent medical help for black stools, vomiting blood, facial swelling, breathing difficulty, a severe rash or reduced urine output. Refer suspected duplicate NSAID therapy, pregnancy or serious disease to the prescriber rather than recommending a replacement.
Promotional or dispensing material must not call the product “100% safe,” “free of side effects” or suitable for everyone.
What regulatory and commercial controls should a Haryana franchise partner verify?
A monopoly territory is a commercial arrangement, not a drug licence. It does not authorise an unlicensed party to sell prescription medicines, override prescription restrictions, or transfer the manufacturer’s responsibility for compliant labelling, batch records, complaints and recalls.
Before entering a general pharma franchise in Haryana, verify these controls in writing:
1. Confirm the applicable wholesale drug licence. Form 20-B covers wholesale allopathic drugs, while Form 21-B applies where the product falls within the relevant Schedule C or C(1) classification. The product’s legal classification, not the term “PCD,” determines the licence.
2. Inspect the premises and storage arrangements. Check cleanliness, security, temperature control, stock segregation, purchase invoices and distribution records. Poor storage can damage a compliant batch.
3. Request the manufacturing licence details, batch number, certificate of analysis, expiry date and available stability information. Match these documents with the physical pack before accepting stock.
4. Ask for a written complaint procedure and recall procedure. It should identify the contact person, response timeline, affected batches, distributor notification method and stock-reconciliation process.
5. Review prescription, labelling and advertising compliance before promotion. Do not use claims such as “100% safe,” “no side effects” or “permanent cure,” and check disease-treatment claims under the Drugs and Magic Remedies (Objectionable Advertisements) Act and applicable labelling rules.
A claimed monopoly cannot correct missing documents, unauthorised sales or unlawful advertising. Documentation is the stronger commercial safeguard.
What is the real benefit of adding this product to a general pharma portfolio?
A two-mechanism product gives a general pharma franchise aceclofenac drotaverine in Haryana a defined portfolio role: prescribers get an option when pain and suspected smooth-muscle spasm occur together. That positioning is also its limitation; it is not a routine choice for uncomplicated back pain, joint pain or muscle strain.
| Option | Portfolio role | Commercial limitation |
|---|---|---|
| Aceclofenac 100 mg + drotaverine 80 mg | Pain with suspected visceral spasm | Narrower use than a general analgesic |
| Aceclofenac 100 mg + paracetamol 325 mg | Pain where an added analgesic mechanism is selected | Does not target smooth-muscle spasm |
| Aceclofenac with thiocolchicoside or chlorzoxazone | Pain involving skeletal-muscle spasm | Not interchangeable with a visceral antispasmodic |
Before appointing an aceclofenac drotaverine tablet franchise, ask for:
- Full composition, including aceclofenac 100 mg and drotaverine HCl 80 mg, on every promotional piece.
- Manufacturing licence details, certificate of analysis, batch number, expiry date and stability information for supplied batches.
- Written supply-continuity terms, minimum order quantities and a process for handling shortages.
- Pharmacovigilance contact details, adverse-event reporting steps, complaint handling and product-recall procedure.
- Territory boundaries, exclusivity conditions and the documents proving what the agreement actually covers.
- Stock-rotation rules, near-expiry replacement terms and written delivery conditions.
Varmed Pharma Pvt Ltd is worth assessing only against these records and operating commitments. A claimed monopoly does not replace a wholesale licence, compliant labelling, batch traceability or reliable delivery. For an aceclofenac 100 mg distributor or drotaverine 80 mg pharma distributor, documented performance is the purchasing benefit.
Related product
 | TABLET Aceclofenac 100 mg + Drotaverine HCl 80 mg ₹120 PUREACE-SPAS Tablet Composition: Aceclofenac 100 mg + Drotaverine HCl 80 mg PUREACE-SPAS Tablet combines a potent anti-inflammatory analgesic with a... View product → |
Frequently asked questions
When does aceclofenac plus drotaverine fit a patient’s pain pattern?
It fits colicky or cramping gastrointestinal, biliary, or urinary-tract pain when smooth-muscle spasm accompanies pain and inflammation. It is not a universal painkiller.
How should you compare this tablet with other aceclofenac combinations?
Compare the active ingredients, strengths, intended pain pattern, contraindications, interaction risks, and whether the added ingredient addresses a documented clinical need.
What counselling and safety checks must accompany every supply?
Check NSAID-related risks, allergy history, gastrointestinal disease, kidney or liver problems, pregnancy status, concurrent medicines, and explain the prescribed dose and referral warning signs.
What regulatory and commercial controls should a Haryana franchise partner verify?
Verify the supplier’s drug licence details, product composition, batch number, expiry date, packaging, invoices, quality documents, storage instructions, and written territory terms before distribution.
Keywords
